Extracellular volume quantification in isolated hypertension - changes at the detectable limits?

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Treibel, Thomas A ^a   Zemrak, Filip ^b   Sado, Daniel M ^a   Banypersad, Sanjay M ^a   White, Steven K ^a   Maestrini, Viviana ^a   Barison, Andrea ^a,c   Patel, Vimal ^a   Herrey, Anna S ^a   Davies, Ceri ^b   Caulfield, Mark J ^b   Petersen, Steffen E ^b   Moon, James C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Hypertension; Left ventricular hypertrophy; Magnetic resonance imaging; Myocardial fibrosis; T1 mapping

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; COLLAGEN; GADOLINIUM; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTRACELLULAR SPACE; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; BLOOD; BLOOD PRESSURE; CARDIAC MUSCLE; CARDIOMYOPATHY, HYPERTROPHIC; CASE CONTROL STUDY; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECTS; ENGLAND; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; TERTIARY CARE CENTER; YOUNG ADULT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; COLLAGEN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FIBROSIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LONDON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE VOLUME; TERTIARY CARE CENTERS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 84938932669     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0176-3     Document Type: Article

References (35)

1. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens. 1998;16:1031-41.
2. Pardo Mindan FJ, Panizo A. Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J. 1993;14:12-14.
3. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993-1003.
4. Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch. 1997;431:265-73.
5. Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009;53:284-91.
6. Zemrak F, Petersen SE. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis. 2011;54:215-29.
7. Ismail TF, Prasad SK, Pennell DJ. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart. 2012;98:438-42.
8. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262-70.
9. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-44.
10. Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24:61-8.
11. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373-83.
12. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932-7.
13. Janardhanan R, Adenaw N, Jiji R, Brooks J, Epstein FH, Kramer CM, et al. Quantifying myocardial fibrosis in hypertensive left ventricular hypertrophy using T1 mapping. J Cardiovasc Magn Reson. 2012;14:1-2.
14. Mongeon F-P, Jerosch-Herold M, Coelho-Filho OR, Seabra LF, Watanabe E, Blankstein R, et al. Identification of myocardial extracellular matrix expansion by cardiac MRI in hypertensive patients. J Cardiovasc Magn Reson. 2011;13:O109.
15. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: National Institute for Health and Clinical Excellence: Guidance]; 2011.
16. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-86.
17. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-23.
18. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.
19. Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging. 2010;3:144-51.
20. Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, et al. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 2008;9:438-48.
21. Osranek M, Seward JB, Buschenreithner B, Bergler-Klein J, Heger M, Klaar U, et al. Diastolic function assessment in clinical practice: the value of 2-dimensional echocardiography. Am Heart J. 2007;154:130-6.
22. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995;26:485-90.
23. Lehmann ED, Parker JR, Hopkins KD, Taylor MG, Gosling RG. Validation and reproducibility of pressure-corrected aortic distensibility measurements using pulse-wave-velocity Doppler ultrasound. J Biomed Eng. 1993;15:221-8.
24. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657-63.
25. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417-26.
26. Muller-Brunotte R, Kahan T, Lopez B, Edner M, Gonzalez A, Diez J, et al. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Hypertens. 2007;25:1958-66.
27. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58:1271-9.
28. Kuruvilla S, Janardhanan R, Antkowiak P, Keeley EC, Adenaw N, Brooks J, et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging. 2015;8:172-80.
29. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436-41.
30. Liu CY, Chang Liu Y, Wu C, Armstrong A, Volpe GJ, van der Geest RJ, et al. Evaluation of Age related Interstitial Myocardial Fibrosis with Cardiac Magnetic Resonance Contrast-Enhanced T Mapping in the Multi-ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2013;62(14):1280-7.
31. Maestrini V, Treibel TA, White SK, Fontana M, Moon JC. T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure. Curr Cardiovasc Imaging Rep. 2014;7:9287.
32. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955-62.
33. Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson. 2011;13:16.
34. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, et al. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012;14:26.
35. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.